Europe Food Allergy Market

Europe Food Allergy Market Size & Forecast:

• Europe Food Allergy Market Size 2025: USD 2.36 Billion 
• Europe Food Allergy Market Size 2033: USD 4.30 Billion 
• Europe Food Allergy Market CAGR: 7.81% 
• Europe Food Allergy Market Segments: By Allergen Type (Milk Allergy, Peanut Allergy, Egg Allergy, Shellfish Allergy, Wheat Allergy, Soy Allergy, Tree Nut Allergy, Others); By Diagnosis (Skin Prick Test, Blood Test, Oral Food Challenge, Patch Test, Molecular Diagnostics, ELISA, Rapid Testing, Others); By Treatment (Antihistamines, Epinephrine, Immunotherapy, Elimination Diets, Biologics, Oral Immunotherapy, Emergency Care, Others); By End User (Hospitals, Clinics, Diagnostic Centers, Research Institutes, Specialty Centers, Homecare Settings, Ambulatory Centers, Others); By Age Group (Pediatric, Adult, Geriatric, Infants, Adolescents, Young Adults, High-Risk Individuals, Others) 

Europe Food Allergy Market Summary

The Europe Food Allergy Market was valued at USD 2.36 Billion in 2025. It is forecast to reach USD 4.30 Billion by 2033. That is a CAGR of 7.81% over the period.

The Europe Food Allergy Market is about finding, handling and stopping bad reactions to food that people have. These reactions happen when the bodys immune system overreacts to food ingredients. This market involves hospitals, clinics, food makers and labs that test for allergies.

In life this market helps find allergies early through testing. It also guides doctors on how to treat emergencies. Helps food companies make products safer by changing ingredients. This makes sure food labels are accurate which reduces the risk of people being hospitalized because of reactions. It also helps food makers follow the rules.

Over the few years there has been a big change in how food allergies are tested. Advanced testing methods can now identify foods that cause allergies, not just broad categories. Stricter food labeling rules in the EU have driven this change. There have been cases of food contamination, which has led to these new rules. As a result doctors and food makers are using precise testing and monitoring systems.Now there's demand for quick testing kits and complete allergy management solutions. This has led to people getting help early and there are fewer severe allergic reactions, in Europe. The Food Allergy Market is helping people get the treatment and stay safe. Food allergy testing is getting better. It is making a difference.

Key Market Insights

• The Europe Food Allergy Market started to use precise testing methods between 2021 and 2026. This change helped identify allergens accurately. It reduced the reliance on broad-category testing in clinics.
• The Europe Food Allergy Market grew more in Western Europe. By 2025 this area had 42 percent of the market. The growth was due to healthcare systems and more access to testing.
• Northern Europe grew the fastest from 2024 to 2030. This was because of the use of health tools and more people getting preventive allergy screenings.
•  More places started using kits after 2022. These kits replaced the skin-prick method in hospitals and allergy centers across Europe.
• Food challenge testing became more common in care. This was due to children having allergies and better safety measures in clinics.
• Hospitals remained the users of allergy diagnostics making up almost 48 percent of the market in 2025. This was helped by insurance policies.
• Companies like Thermo Fisher Scientific and Danaher made their testing platforms better. They used Artificial Intelligence to make labs work automatically. This made tests quicker and processing time shorter.
• ALK-Abelló and Stallergenes Greer worked on making allergy vaccines. They also made partnerships with companies in Europe. This was to make treatments that help people with allergies work better.
• There were some problems, with food safety. So in 2022 the rules became stricter. This made diagnostics companies and food manufacturers work together. They wanted to track allergens and make safety systems better.

What are the Key Drivers, Restraints, and Opportunities in the Europe Food Allergy Market?

Drivers

The Europe Food Allergy Market is driven by the European Union making rules new technologies for diagnosing allergies becoming more advanced. The European Union made these rules stricter because there were cases of allergic reactions from food that was packaged. This made food companies and hospitals use systems to detect and monitor allergies. As a result the Europe Food Allergy Market is seeing demand for tests that can detect allergies and programs that screen for allergies in hospitals. This means that companies that provide tests for allergies are making money.

Restraints

The Europe Food Allergy Market has an issue. The equipment used to test for allergies is really costly and many hospitals cannot buy it. This is particularly true for hospitals in areas and small hospitals. The cost of this equipment is so high that only large hospitals in cities are able to pay for it. As a result the Europe Food Allergy Market is affected because not all patients can get the tests and it takes more time to figure out if someone has an allergy. The Europe Food Allergy Market does not grow quickly in some parts of Europe because of this problem, with the Europe Food Allergy Market.

Opportunity

There is an opportunity for the Europe Food Allergy Market to grow. Some countries, like Germany and the Netherlands are using computers to predict allergies. They are using patient records and genetic information to predict who might have a reaction. If this is used over Europe it can help doctors stop allergic reactions before they happen. It can also help companies make treatments that are tailored to each patient. This can open up ways for companies to make money by preventing allergies and making personalized treatments. The Europe Food Allergy Market can grow if this approach is used widely.

What Has the Impact of Artificial Intelligence Been on the Europe Food Allergy Market?

The Europe Food Allergy Market is getting better because of intelligence. Artificial intelligence is helping to make things more efficient by making diagnostic workflows simpler and reducing the need for people to interpret results in allergy testing laboratories. Hospitals and diagnostic centers are using tools that have artificial intelligence to recognize images and analyze allergy tests, like skin-prick and blood-based tests. This helps to reduce mistakes made by people and makes things faster.Laboratory automation platforms that work with health systems help doctors take care of more patients without making mistakes in diagnosing people.

Artificial intelligence is also used to predict if someone will have an allergy by looking at their health records what they eat and what they are allergic to in their area. This helps doctors find people who're at high risk of having an allergy and make a plan to prevent it. It also reduces the need for emergency help. In some hospitals in the European Union tools that help make decisions have made it possible to get results faster which means people can get treated sooner and resources can be used better.

With all these good things there is still a problem. The problem is that there is not good quality data about allergies in European healthcare systems. This makes it hard to make intelligence models that work well. Also there are rules about keeping peoples health information private which makes it hard to share data and train intelligence models to be better. This slows down the use of digital systems to manage allergies. The Europe Food Allergy Market and artificial intelligence are important, for making things better.

Key Market Trends

• The Europe Food Allergy Market saw an increase after the 2021 EU labeling reforms. These reforms made sure that all packaged food had to say what allergens were in them. This was a change for the Europe Food Allergy Market.
•  Companies that make tools started using new ways to test for allergies between 2022 and 2025. They moved away from the way of testing, which was called IgE testing. The new way is called component-resolved diagnostics. This new way is much better at finding allergies.
• Hospital labs started using computers to help with allergy tests in 2023. This made the tests more accurate and faster. The hospital labs were able to do tests and make fewer mistakes.
• Germany and France gave money to programs that track allergies in 2024. This helped the countries keep track of allergies and make better decisions about how to treat them.
• Food companies started using tools to track their food after some problems in 2022. These problems showed that some food had hidden allergens in it. The digital tools helped the companies keep their food safe.
• More and more people in Europe wanted to get their kids tested for allergies after 2023. This was because more kids were getting allergies in cities. The Europe Food Allergy Market saw a shift towards testing kids for allergies.
• Some pharmaceutical companies like Sanofi started working on treatments for allergies between 2022 and 2025. They made medicines that were just for allergies.
• Doctors and hospitals started using health tools with their patient records after 2023. This helped them see what was going on with their patients and what they were allergic to.
• The people in charge of food safety made rules in 2024. These rules helped keep food safe by making sure that all countries were working together to track allergens.
• More and more labs started using computers to help with allergy tests. This was because the old way of doing tests was slow and had a lot of mistakes. The labs wanted to get faster and more accurate. The Europe Food Allergy Market was getting better at testing, for allergies.

Europe Food Allergy Market Segmentation

By Diagnosis:

The way they diagnose food allergies in Europe is changing. They are moving away from skin tests and towards molecular diagnostics and ELISA systems. After 2022 hospitals started using blood tests often because they are more accurate and safer for patients. They also started using testing tools in outpatient clinics, which helped them screen patients faster and reduced waiting times in hospitals and clinics.

By Treatment:

The way they treat food allergies in Europe is also changing. They are using biologics and immunotherapy often because there are more severe allergy cases. Epinephrine is still the option for emergency responses but they are also using oral immunotherapy more often after 2023 to control allergies in the long term. Hospitals are also helping patients with diets and monitoring their nutrition.

By End User:

Hospitals are the place where food allergies are diagnosed and treated in Europe because they have good equipment and many patients. After 2022 diagnostic centers started to use testing more often which made them more accurate and efficient. People are also using testing kits at home which helps them detect food allergies early and monitor their condition outside of hospitals.

By Age Group:

Most food allergy cases in Europe are in children and babies because they are exposed to foods early and their diets are changing. After 2023 hospitals started to screen babies for food allergies, which helps them detect the problem early. There are also cases of food allergies in adults in cities because they are eating more processed foods and their diets are changing. Europe Food Allergy Market is seeing these changes, in the Europe Food Allergy Market.

What are the Key Use Cases Driving the Europe Food Allergy Market?

The main reason the Europe Food Allergy Market is growing is because of the screening that happens in hospitals. This is because more and more kids are getting food allergies and the rules about food safety are getting stricter. In hospitals doctors use blood tests and other methods to figure out if someone's allergic to something. They do this to prevent bad reactions. This is the important use of diagnostic screening because it helps catch allergies early which means fewer people have to go to the emergency room and it saves money on treatment in the long run.

There are places that are starting to use diagnostic screening too. For example special clinics are using tests to help people who have allergies. They are doing this because more and more people are getting allergies from the food they eat. This is especially true in cities where people eat a lot of processed food and are more likely to come into contact with things they're allergic to.

Now people are starting to use Europe Food Allergy Market screening at home. There are kits that people can use to test themselves for allergies. This is really helpful for kids and people who're at high risk of having a bad reaction. Some people are even using tools to track their allergies and get personalized advice on what to eat. This is all part of an effort to prevent people from getting sick in the first place and it is supported by public health systems, in Europe and the Europe Food Allergy Market.

Which Regions are Driving the Europe Food Allergy Market Growth?

Western Europe leads the Europe Food Allergy Market due to strong healthcare infrastructure and strict food safety regulations enforced across the European Union. Countries like Germany, France, and the United Kingdom maintain advanced diagnostic networks supported by specialized allergy clinics and hospital-based testing programs. Mandatory allergen labeling laws in packaged food industries further strengthen early detection and reporting systems. A mature pharmaceutical ecosystem and high awareness among healthcare professionals support consistent adoption of advanced diagnostic and treatment solutions. This combination of regulation, clinical readiness, and consumer awareness sustains Western Europe’s dominant position in the market.

Northern Europe remains a stable and steady contributor to the Europe Food Allergy Market, driven by strong public healthcare systems and consistent government funding for preventive care. Countries such as Sweden, Denmark, and the Netherlands emphasize early screening programs and standardized allergy management protocols. Unlike Western Europe, growth here is less driven by regulatory pressure and more by long-term healthcare planning and patient trust in public medical systems. High per-capita healthcare spending ensures steady adoption of molecular diagnostics and hospital-based allergy testing services. This stability supports predictable revenue contribution from the region over time.

Southern and Eastern Europe show the fastest growth in the Europe Food Allergy Market due to recent improvements in healthcare infrastructure and rising awareness of food-related health risks. Increased adoption of EU-aligned food safety regulations after 2022 has accelerated diagnostic expansion in countries such as Italy, Spain, Poland, and Romania. Investment in hospital modernization and diagnostic laboratory upgrades has improved access to allergy testing services. Growing urban populations and changing dietary habits are increasing demand for clinical allergy management. This growth trend signals strong entry opportunities for diagnostic providers and healthcare investors over the 2026–2033 period.

Who are the Key Players in the Europe Food Allergy Market and How Do They Compete?

The Europe Food Allergy Market remains moderately consolidated, with established pharmaceutical and diagnostic companies holding significant positions while specialized biotechnology firms introduce targeted innovations. Competition depends primarily on technology, clinical evidence, regulatory approvals, and broad distribution networks rather than pricing alone. Established manufacturers continue defending market share through expanded biologic portfolios, advanced diagnostic platforms, and long-term healthcare partnerships. New entrants focus on precision diagnostics and oral immunotherapy, creating competition in selected treatment segments instead of the entire market.

ALK-Abelló strengthens market presence through allergen immunotherapy products supported by extensive clinical research and strong physician engagement across European countries. Thermo Fisher Scientific differentiates through molecular allergy diagnostics that improve test accuracy and help clinicians identify specific allergen sensitivities with greater confidence. Stallergenes Greer focuses on allergy immunotherapy and expands regional access through collaborations with healthcare providers and continuous product development.

Sanofi advances growth by expanding immunology research programs and partnering with biotechnology companies to strengthen future treatment pipelines for immune-mediated diseases. Regeneron Pharmaceuticals builds competitive advantage through monoclonal antibody research supported by large clinical development programs and strategic collaborations. Eurofins Scientific expands laboratory testing capabilities across Europe through acquisitions, broader diagnostic service networks, and investments in advanced allergy testing technologies that improve turnaround time and clinical efficiency.

Company List

• Nestlé Health Science

• DBV Technologies

• Aimmune Therapeutics

• Stallergenes Greer

• ALK-Abelló

• Thermo Fisher Scientific

• Danaher

• Sanofi

• Pfizer

• Novartis

• GSK

• Siemens Healthineers

• Roche

• BioMérieux

• Teva Pharmaceutical Industries

Recent Development News

• In March 2025, DBV Technologies secured financing of up to €284.5 million to advance the development and planned commercialization of its VIASKIN® Peanut patch. The funding strengthens the company's food allergy pipeline and supports regulatory activities for one of the leading investigational therapies targeting peanut allergy.https://live.euronext.com
• In June 2025, DBV Technologies presented new clinical data at the EAACI 2025 Congress, including results from its APTITUDE Phase II study conducted in collaboration with Nestlé Health Science. The findings advanced research on non-IgE-mediated cow's milk allergy diagnosis and reinforced the companies' strategic collaboration in pediatric food allergy management.https://www.globenewswire.com
• In March 2025, DBV Technologies received FDA agreement on the safety package required for its Biologics License Application for VIASKIN® Peanut. The regulatory milestone accelerated the expected submission timeline and strengthened the commercial outlook for an innovative peanut allergy therapy with potential relevance for European markets.https://www.globenewswire.com

What Strategic Insights Define the Future of the Europe Food Allergy Market?

The Europe food allergy market is moving toward a more proactive, diagnostics-led and treatment-integrated model, where early detection and disease-modifying therapies gradually replace purely avoidance-based management. Over the next five to seven years, growth will be driven by rising pediatric allergy prevalence, stronger clinical standardization across European healthcare systems, and accelerating development of immunotherapies such as oral and patch-based desensitization treatments. This shift is also reinforced by increased collaboration between biotech firms and diagnostic leaders aiming to close the gap between testing and long-term disease control.

A less obvious risk is uneven reimbursement coverage across European countries, which could restrict patient access to advanced immunotherapies despite strong clinical progress. An emerging opportunity lies in biomarker-driven personalized allergy treatment pathways, particularly as precision immunology tools begin to identify patient subgroups more likely to respond to specific therapies. Market participants should prioritize scalable immunotherapy platforms supported by strong clinical evidence generation and actively engage with national health authorities to secure reimbursement alignment early in the product lifecycle.

Europe Food Allergy Market Report Segmentation

• By Allergen Type

• Milk Allergy
• Peanut Allergy
• Egg Allergy
• Shellfish Allergy
• Wheat Allergy
• Soy Allergy
• Tree Nut Allergy
• Others

• By Diagnosis

• Skin Prick Test
• Blood Test
• Oral Food Challenge
• Patch Test
• Molecular Diagnostics
• ELISA
• Rapid Testing
• Others

• By Treatment

• Antihistamines
• Epinephrine
• Immunotherapy
• Elimination Diets
• Biologics
• Oral Immunotherapy
• Emergency Care
• Others

• By End User

• Hospitals
• Clinics
• Diagnostic Centers
• Research Institutes
• Specialty Centers
• Homecare Settings
• Ambulatory Centers
• Others

• By Age Group

• Pediatric
• Adult
• Geriatric
• Infants
• Adolescents
• Young Adults
• High-Risk Individuals
• Others